LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

No!!he writes a little different when he holds

i don't think it makes someone's views invalid just because he doesn't hold shares in a particular company ..... but then i would say that, wouldn't i!

Do you think he could turn the water to fruitflow instead of wine???

for our muslim brethren, i am sure that would be a possibility

And which stocks do I hold Tabasco? As I recall you 'squelched' me some time ago due to my comments on the MDX thread (on which incidentally I was proven entirely correct).

MP, sorry if my comments are on the negative side. I am not anti PXS per se, but rather the hype and ramping that surrounds this share at the moment. I sincerely hope it makes all holders a zillion pounds, but for a penny share it needs to have that killer product, have the funds to market it, whilst at the same time fighting off any predators. Can you be sure that the Directors wouldn't seetle for a quick million and sell to Coca Cola or whoever else. In the mean time the PI (as always) gets shafted.

Blanche, why would I be bitter and twisted? I'm happy to see others (even Tabasco) make money. I think you might just be a little bitter as your greed got the better of you. From your own account you bought 10ks worth at 1p, sold a few to cover the investment and then watched as it made an intra-day high of 23p, which must have represented a paper profit in excess of 150k. Absolutely barking not to sell, no wonder you're pissed off. As the old adage goes, a long term investment is a short term investment gone wrong. In any event good luck.

PTH-thanks for the reply--I can't disagree with your comments. Let's hope this co. is the exception.

i would be delighted if PXS got gobbled up, so long as it's at a decent premium to what i paid

Pth- my comment wasn`t aimed at you. And why would i sell as i invested long term in this company,Its one of a few shares i hold which i think has a massive future, therefore iam holding out for the really big bucks. For another example Afren average 23p wont be selling til end of 2010 for less then 3.00. Not every share is buy and sell, buy and sell. Its a fine balance of trading and long term shares. everybody has their own way of doing things. . gl2u2

IN THE GUARDIAN. CO UK ....'Keeps the blood cool!" "Makes red blood redder!" "Will correct stomach troubles!" The trick of making a health claim to sell your factory food is nothing new, as these 19th-century slogans from cereal packs show. They are among my favourites on display in the Kellogg's museum of cereal history in Battle Creek, Michigan. Alongside the cases of antique cardboard boxes of products delighting in such names as Vim, Vigor, Korn Kinks and Climax, are records of the original grape nuts, sold not only as "brain food" but as a cure for consumption and malaria, and perhaps most remarkable, given their hardness, as an antidote to loose teeth. It was the inventor of grape nuts, Charles Post, who distributed an early food marketing pamphlet entitled The Road to Wellville, because, as he pointed out, advertising is "the sunshine that makes a business plant grow".

The food industry has been keen to keep us all on the lucrative Road to Wellville ever since and while we may have no difficulty seeing through the ludicrously exaggerated claims made for new products a century ago, we seem to have been happy to buy into today's equivalent, the booming market in so called "functional foods" that promise to cure everything from indigestion to memory loss and lethargy.

Unfortunately for the industry, last week the European Food Safety Authority (EFSA) rejected about 350 claims made for a swathe of food products currently marketed as good for your health. Under new EU rules on labelling, being introduced after years of pressure from consumer groups, EFSA has been asked to review the scientific evidence for health claims made by food manufacturers. The idea is that eventually only those claims supported by robust science will be allowed on products, and only then if the product overall meets healthy requirements on fat, salt and sugar content. EFSA has just completed part of that review and found that two-thirds of about 500 claims submitted are unfounded.

Out of hundreds of "probiotic" strains of bacteria under consideration, not one was shown to improve gut health or immunity. Taurine, the amino acid added to energy and sports drinks, was not found to boost energy. Nor was there evidence to support the claim that glucosamine is beneficial for joints, although it is widely marketed as such.

EFSA still has a long way to go. As part of the tightening up of rules around health claims, from 2007 individual member states were asked to collect the claims being made by their industries and submit them to the authority for scrutiny. A staggering 44,000 claims were sent in to the Parma-based authority for its team of independent scientists to give an opinion on whether they were true or not. These have been whittled down to around 4,000 for which there might at least be some evidence. Last week's batch of 350 rejections was of claims that relate to general health, such as "boost the immune system" or "improves mental performance". EFSA has yet to look at other claims for products that are more specific or suggest that they may reduce disease.

The leading manufacturers of probiotics were quick to point out that their own claims have not yet been assessed by EFSA. Danone withdrew its original claims for Actimel and Activia products earlier this year, saying it would resubmit them. Yakult has submitted scientific dossiers for its probiotic drinks under a different category, yet to be examined.

Neverthless the recent rulings represent a hammer blow to the food and supplements industry. The exponential growth in "functional foods" began in the 1990s when manufacturers were increasingly under pressure from supermarkets using their dominance to squeeze suppliers' margins. Packaging highly processed foods up with health claims was one way for brands to maintain a premium in a saturated market.

The claims that did make it through the EFSA process last week were mostly for vitamins, minerals and dietary fibre. But affirmation that calcium, available in milk, and meat and eggs, is good for bones or that iron, available in dark green leafy vegetables and wholemeal bread as well as meat, is good for blood function, does not present quite the same scope for proprietary profit.....................................................
FRUITFLOW TECHNOLOGY IS UNIQUE.

Link to today's RNS:

Update on human trials - re Fruitflow vs aspirin

Stephen Moon, CEO of Provexis commented:

"We are very pleased that these interim results highlight the potential of Fruitflow as an effective and safe dietary supplement which significantly reduces platelet aggregation in all users. This is our tenth placebo controlled human trial and together with the recent European Food Safety Authority endorsement of the science it further highlights the potential of Fruitflow."

Rubbing hands together already.... good news... market likes it.

As a point of interest, I am a type 2 diabetic and have always struggled to keep my blood sugar level within the recommended 4 to 7 reading, averaging around 7.5. I have been drinking Sirco regularly for just 2 weeks, my average reading is already down to 6.2, with a lowest reading of 5.2, highest 6.9. I do not think that this is just coincidence.

i read it, and though certainly positive, it didn't look exactly sufficient to set the world on fire.

i hold pxs - this one has legs - will be a success - lots going on imo - GL all

until it gets DVT and requires an amputation

kim--that's a very positive post I'm pleased for you and I hope any other diabetics try it and benefit. Far more important than monetary gain.

i believe it's the sticky buns and beer that play havoc with blood sugar readings!

mp, that is very true!

I might just be able to have a couple of sticky buns with my pint now cynic! :o)

yep cycnic a pint sounds good - had me buns earlier!

are you offering to buy cynic.... must be your round by now.......... there he goes off on his bike again, new there was a reason for you going to france. :)